Histological, molecular and functional subtypes of breast cancers
about
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesEmerging role of cell polarity proteins in breast cancer progression and metastasisDerivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cellsNew breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology imagesBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Genetically engineered ERα-positive breast cancer mouse models.Breast Cancer: Exploring the Facts and Holistic Needs during and beyond Treatment.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational StudyBreast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarkerClinicopathological significance of dual-specificity protein phosphatase 4 expression in invasive ductal carcinoma of the breastGenotype/Phenotype correlations in patients with hereditary breast cancerAberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: a pilot study.Mouse models of estrogen receptor-positive breast cancerTransformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancerp53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer.Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models.MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon).Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer.A lectin-based approach to detecting carcinogenesis in breast tissue2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography after breast conserving surgery: Correlation with molecular markers of breast cancerFuture Prospects in Breast Cancer Research - Cancer Stem Cells.Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment.ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL.Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer.Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.The role of oxidative stress on breast cancer development and therapy.Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies.Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population.In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.Cats, Cancer and Comparative OncologyTargeting the Stem Cell Properties of Adult Breast Cancer Cells: Using Combinatorial Strategies to Overcome Drug Resistance.
P2860
Q26783705-1E2F87A5-F30C-4122-9088-25E3C7810E95Q26851833-2AB69846-3BF0-4631-9FEB-F719817E7170Q28482309-C680ECDB-1206-4EFF-8706-AAEE1BCB1660Q28646873-0FE15241-B526-48FF-9E09-371087B73661Q30245184-B6A374A8-A0EE-4094-A5CC-8E4E613C0ECAQ33578641-B1ED77DD-BF36-4F90-82AF-50DAEB40792FQ33856007-7E7AC76D-E40F-49BD-8575-86213064E86AQ33858073-52B74AAD-8ACD-4004-B69A-8CCB2E91B1B8Q34269541-4EA6D074-377D-4919-BD08-F83F083D20B5Q34323234-C4068952-23E1-4DE5-B775-1524311FC715Q34336219-0F5F42B7-156F-4F84-BA9F-B5B545D24019Q34472094-5D4E977A-6FF9-4B37-8F7B-752194DA94BFQ35237192-E8A7209E-2FD9-4D71-9505-842E3DEDA03AQ35399541-56CBA60D-FF45-4D11-8C56-010D0DD3DF5AQ35632602-A295050E-C37D-4369-81BC-C40DBB566FB0Q35685892-1C9EE2C6-BBB3-4C56-AC74-1A3DBF13B313Q36110157-9A7ACF2D-0D5C-4904-B0C3-AFD89B675844Q36245363-7F2A4185-9A0A-4C7C-9AAD-8333FAEF8EDAQ36688072-A8725DE0-794E-4563-9C0F-F4C202FE872DQ36700083-D447BFB5-BD7C-4EC1-A617-C79686C11F96Q36708704-75BA45A2-CE9B-4A0E-94A7-99159A6D9013Q36947561-D540A7B8-EFB6-4377-9D35-EF43344CFC81Q36954600-13B3E373-53E2-4BD3-BA4A-5042FED1D57FQ37032065-FD95FE99-F004-42C1-B7FC-1329A2ABE62BQ37155217-CB2B7199-52D2-4CF4-9601-64ED1D40A12AQ37164587-92B85876-5764-4CAF-A344-204C2944D152Q37222882-EE061491-E4CF-4250-A8D9-D0096296864BQ37419375-C20E99BD-00AC-4193-861F-4D6CD0357453Q37558516-97B8F2A6-C628-4CC6-8928-2A33A4ACB1CAQ38149106-74305886-8A0E-4D41-80DC-6CFAA2B23BB9Q38232507-76CCB880-AE4C-48CB-9911-5DB3AFCBD97CQ38578970-7D0527B2-6C8D-4465-A9B3-17E28738FCBBQ38713186-08EDA804-948A-4F9B-B682-C2CAA3F5DA63Q38947310-B50291EB-24A4-481C-B79B-9E47C76D5EB9Q39149219-B9251211-C4D7-4340-83E6-50A9B425E700Q40248157-3991D17F-E91A-49BC-A86A-5B885D6D6613Q40866227-2816D6B3-9532-4B2B-8E1A-B4A918AA5105Q41051383-EC9AEE28-CEFF-4802-BE3C-5181121DF7EDQ42698528-8595E259-5EF5-4C92-AA89-2F6717DDDBE8Q45073326-D5EB9F15-C06B-40EB-98C7-57EB1D29D13A
P2860
Histological, molecular and functional subtypes of breast cancers
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Histological, molecular and functional subtypes of breast cancers
@ast
Histological, molecular and functional subtypes of breast cancers
@en
Histological, molecular and functional subtypes of breast cancers
@nl
type
label
Histological, molecular and functional subtypes of breast cancers
@ast
Histological, molecular and functional subtypes of breast cancers
@en
Histological, molecular and functional subtypes of breast cancers
@nl
prefLabel
Histological, molecular and functional subtypes of breast cancers
@ast
Histological, molecular and functional subtypes of breast cancers
@en
Histological, molecular and functional subtypes of breast cancers
@nl
P2093
P2860
P356
P1476
Histological, molecular and functional subtypes of breast cancers
@en
P2093
Gautam K Malhotra
Hamid Band
Vimla Band
Xiangshan Zhao
P2860
P304
P356
10.4161/CBT.10.10.13879
P577
2010-11-15T00:00:00Z